$4450
$3560
The continuous glucose monitoring device (CGMD) market size is projected to reach US$ 33.21 billion by 2031 from US$ 12.71 billion in 2024. The market is expected to register a CAGR of 14.9% during 2025–2031.
Continuous Glucose Monitoring Device (CGMD) Market Analysis
The rising global prevalence of diabetes, technological advancements in CGMDs, and benefits over conventional glucose monitoring drive the continuous glucose monitoring device (CGMD) market growth. Additionally, integration with insulin delivery and AI-driven support contributes to market growth. Increasing accessibility in emerging and underserved markets is expected to create ample opportunities for the continuous glucose monitoring device (CGMD) market in the coming years.
Continuous Glucose Monitoring Device (CGMD) Market Overview
North America is projected to dominate the continuous glucose monitoring device (CGMD) market, accounting for the largest share during the forecast period. Moreover, Asia Pacific is expected to register a significant CAGR during the forecast period due to increasing prevalence attributed to urbanization, sedentary lifestyles, dietary changes, and technological advancements. China is confronting a considerable and escalating diabetes epidemic, with projections indicating that by 2050, the country will have ~168 million individuals living with type 2 diabetes, a substantial increase from 2024 figures (148 million), as per the data of IDF. This surge is attributed to urbanization, dietary changes, and aging demographics. The government of China has set ambitious targets to enhance diabetes awareness and management. By 2030, the National Health Commission aims to achieve a 60% awareness rate among individuals aged 18 and above and ensure that 70% of type 2 diabetes patients receive standardized management services at the local level. The growing prevalence of diabetes has spurred advancements in medical technology, particularly in continuous glucose monitoring (CGM).
In response to the growing need for effective diabetes management, the Indian healthcare system has made significant advancements in the availability and reimbursement of CGM devices. Notably, in March 2022, the Ministry of Health, Labour and Welfare (MHLW) approved the extension of reimbursement coverage for Abbott's FreeStyle Libre system to include all individuals with diabetes who use insulin at least once daily. Similarly, in December 2022, Terumo Corporation announced that the Japanese medical insurance system expanded payment coverage for the Dexcom G6 CGM System, making the device more accessible to diabetic patients in Japan. These policy changes have significantly increased the adoption of CGM devices nationwide. The growth is driven by domestic and international companies, including Dexcom, Abbott, Medtronic, and Terumo Corporation, which are actively involved in developing and distributing CGM systems in India.
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Continuous Glucose Monitoring Device (CGMD) Market: Strategic Insights
Market Size Value in US$ 9.8 billion in 2022 Market Size Value by US$ 28.5 billion by 2030 Growth rate CAGR of 14.1% from 2022 to 2030 Forecast Period 2022-2030 Base Year 2022
Mrinal
Have a question?
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Continuous Glucose Monitoring Device (CGMD) Market Drivers and Opportunities
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Continuous Glucose Monitoring Device (CGMD) Market: Strategic Insights
| Market Size Value in | US$ 9.8 billion in 2022 |
| Market Size Value by | US$ 28.5 billion by 2030 |
| Growth rate | CAGR of 14.1% from 2022 to 2030 |
| Forecast Period | 2022-2030 |
| Base Year | 2022 |
Mrinal
Have a question?
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Market Drivers:
Rising Global Prevalence of Diabetes:
The surge in global diabetes prevalence stands as a fundamental growth engine for the CGM market. Recent data reveal a dramatic transformation: the proportion of adults with diabetes has doubled over roughly the past three decades, climbing from ~7% in 1990 to 14% by 2022, now encompassing more than 800 million people worldwide. This puts current prevalence at ~11.1% (or one in nine adults), with projections soaring to 853 million (one in eight adults) by 2050, marking a 46% increase, per the International Diabetes Federation.
Growing Technological Advancements in CGM Devices:
Technological progress in continuous glucose monitoring (CGM) drives market growth by enhancing device accuracy, user experience, and expanding potential use cases. The integration of AI-driven predictive algorithms marks another leap forward. Systems such as Medtronic's Guardian Sensor?4 can forecast glucose fluctuations up to 60 minutes ahead, enabling preemptive alerts and interventions. Broader industry trends indicate growing use of machine learning to model user-specific glucose trends, personalize alerts, and enhance interaction with other health data, pushing CGMs into truly predictive and personalized health tools.Benefits Over Conventional Glucose Monitoring:
CGMs eliminate the practical and psychological burden of frequent finger sticks, a limitation that impaired adherence and quality of life with earlier methods. Children particularly value this finger-prick-free approach, and patients undergoing intensive therapy report higher treatment satisfaction and long-term device retention rates despite cost and device complexity challenges.
Market Opportunities:
Increasing Accessibility in Emerging and Underserved Markets:
A key growth opportunity in the continuous glucose monitoring (CGM) devices market lies in increasing accessibility across emerging and underserved regions, where diabetes prevalence is rising sharply. Yet, access to modern diabetes management tools remains severely limited. However, CGM penetration remains under 5% in many regions, mainly due to high upfront costs, lack of awareness, limited reimbursement, and inadequate healthcare infrastructure. This disparity presents a significant untapped opportunity for both global and local players aiming to expand their reach.
Expanding in Emerging Economies:
Rapid economic growth drives investments in healthcare infrastructure and new medical technologies in countries such as China, India, and South Africa. Initiatives toward reinforcing healthcare sectors include modernizing urological care, raising awareness about early diagnosis, and expanding health insurance coverage.Rising Strategic Initiatives by Market Players:
Companies operating in the continuous glucose monitoring device (CGMD) market frequently pursue strategic initiatives such as product approvals, collaborations, funding, agreements, and new product launches, to improve their sales, increase their geographic reach, expand their customer base, and strengthen market presence.Public-Private Partnerships:
Public-private partnerships offer significant opportunities in the continuous glucose monitoring device (CGMD) market by fostering collaboration between governments and private companies to improve healthcare access. These partnerships can support the development and distribution of advanced CGM technologies, enhance funding for screening programs, and facilitate training initiatives. Such cooperation promotes innovation while expanding the availability of CGM solutions in underserved or remote regions.
Continuous Glucose Monitoring Device (CGMD) Market Report Segmentation Analysis
The continuous glucose monitoring device (CGMD) market is divided into different segments to give a clearer view of how it works, its growth potential, and the latest trends. Below is the standard segmentation approach used in most industry reports:
By Product:
Sensors:
Sensors remain the technological and economic keystone of continuous glucose monitoring (CGM) systems in diabetes care. These small, wearable components are inserted subcutaneously to continuously measure interstitial glucose levels, typically at 5-minute intervals, transmitting real-time data to receivers or smartphones. The CGM sensor market has seen substantial momentum over the past few years, driven by rapid innovation, growing global diabetes prevalence, and greater adoption among Type 1 and, increasingly, Type 2 diabetes patients.Transmitters:
Transmitters are placed on the skin to communicate wirelessly with a sensor inserted beneath the skin. This sensor measures glucose levels in the interstitial fluid. The transmitter sends this data to a receiver or smartphone app, enabling users to monitor their glucose levels and receive high or low blood sugar alerts. CGM devices typically use radiofrequency transmitters, which utilize radio waves to transmit data from the sensor to the receiver or smartphone application. Near-Field Communication (NFC) and Bluetooth transmitters are also used in CGM devices.Receivers:
Receivers, the devices or interfaces that display CGM sensors' glucose readings, are a critical link between sensing and user interpretation. Yet, they often fall into the background amid the spotlight on sensors and transmitters. Recent advancements have reshaped their functionality, format, and integration within broader diabetes-care ecosystems. Historically, many CGM systems offered dedicated standalone receivers.
By Application:
- Type 1 Diabetes
- Type 2 Diabetes
By Testing Sites:
- Fingertip Testing
- Alternate Site Testing
By End User:
- Hospitals and Clinics
- Self or Homecare
By Geography:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
The continuous glucose monitoring device (CGMD) market in North America is expected to hold a significant share of the market. Rising global prevalence of diabetes, technological advancements in CGM devices, and benefits over conventional glucose monitoring by the market players drive the market growth.
Continuous Glucose Monitoring Device (CGMD) Market Report ScopeContinuous Glucose Monitoring Device (CGMD) Market Share Analysis by Geography
Asia Pacific is expected to grow the fastest in the next few years. Emerging markets in Latin America, the Middle East, and Africa also have many untapped opportunities for continuous glucose monitoring devices providers to expand.
The continuous glucose monitoring device (CGMD) market growth is attributed to the increasing prevalence of diabetes, well-established healthcare infrastructure, and rapid adoption of cutting-edge technologies. Below is a summary of market share and trends by region:
1. North America
Market Share:
Holds a significant portion of the global marketKey Drivers:
- Increasing prevalence of diabetes
- Technological advancement
- Favorable regulatory & reimbursement environment
-
Trends:
AI Integration Across the Value Chain.
2. Europe
Market Share:
Substantial share due to the increasing prevalence of diabetesKey Drivers:
- Increasing prevalence of diabetes
- Intensified research and development activities
- The launch of advanced technologies across Europe
Trends:
Device miniaturization & smart tech integration
3. Asia Pacific
Market Share:
Fastest-growing region with a rising market share every yearKey Drivers:
- Demand for smart and innovative CGMDs
- Rising prevalence of diabetes
- Rapid improvements in healthcare infrastructure, supported by increasing government investments in public health.
Trends:
Technological advancement
4. South and Central America
Market Share:
Growing market with steady progressKey Drivers:
- High prevalence of diabetes
- Growing healthcare investments and infrastructure development
Trends:
Growing adoption of cutting-edge CGMD technology
5. Middle East and Africa
Market Share:
Although small, but growing quicklyKey Drivers:
- Expanding healthcare infrastructure
- Increased public awareness emphasizes the importance of early diabetes condition diagnosis
Trends:
The adoption of telemedicine and remote device support
Continuous Glucose Monitoring Device (CGMD) Market Players Density: Understanding Its Impact on Business Dynamics
High Market Density and Competition
Competition is strong due to the presence of established players such as Abbott Laboratories; Dexcom Inc.; Ypsomed Holding AG. Regional and niche providers such as A. Menarini Diagnostics s.r.l and Medtrum Technologies Inc. are also adding to the competitive landscape across different regions.
This high level of competition urges companies to stand out by offering:
- Advanced Products
- Value-added services such as customization and sustainable solutions
- Competitive pricing models
- Compliance with regulatory guidelines
Opportunities and Strategic Moves
- Growing preference for innovative and advanced glucose monitoring drives demand for CGMDs. Opportunity for innovation in portable, easy-to-use monitoring devices.
- Companies emphasize clinical studies and regulatory approvals (including FDA clearances for new product categories), building strong clinical evidence to support adoption in hospitals and outpatient settings.
- Companies are targeting high-growth, under-penetrated markets in Asia Pacific and Latin America to expand, build local partnerships, and increase training initiatives. Manufacturers from Asia Pacific are launching hybrid and price-competitive solutions for emerging markets.
Major Companies operating in the Continuous Glucose Monitoring Device (CGMD) Market are:
- Abbott Laboratories
- Dexcom Inc.
- Ypsomed Holding AG
- Medtronic
- F. Hoffmann-La Roche Ltd
- Senseonics Holdings Inc
- i-SENS Inc.
- A. Menarini Diagnostics s.r.l
- Tandem Diabetes Care, Inc.
- Medtrum Technologies Inc.
Disclaimer: The companies listed above are not ranked in any particular order.
Other companies analysed during the course of research:
- GlySens Incorporated
- Echo Therapeutics, Inc.
- B. Braun SE
- Agamatrix Inc
- PHC Holdings Corporation
- Nemaura Medical Inc.
- Zhejiang POCTech Co., Ltd.
- MicroTech Medical
- Sinocare
- Med Trust
- Bigfoot Biomedical Inc.
Tracky launches India's first bluetooth-connected continuous glucose monitor
To tackle one of the country's most pressing health challenges, Thane-based startup Tracky, an innovative healthtech brand by DrStore Healthcare Services, has officially launched - India's first Bluetooth-enabled Continuous Glucose Monitor (CGM).
FDA clears Dexcom G7 15-Day continuous glucose monitor
Dexcom announced it had received FDA clearance for its Dexcom G7 15-Day continuous glucose monitoring system for use in adults aged 18 and older. The system extends wear time to 15.5 days. It reports a mean absolute relative difference of 8.0%, making it one of the most durable and high-performing continuous glucose monitoring devices currently authorized in the US market.
Continuous Glucose Monitoring Device (CGMD) Market Report Coverage and Deliverables
The "Continuous glucose monitoring device (CGMD) market Size and Forecast (2021–2031)" report provides a detailed analysis of the market covering below areas:
- Continuous glucose monitoring device (CGMD) market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
- Continuous glucose monitoring device (CGMD) market trends, as well as market dynamics such as drivers, restraints, and key opportunities
- Detailed PEST and SWOT analysis
- Continuous glucose monitoring device (CGMD) market analysis covering key market trends, global and regional framework, major players, regulations, and recent market developments
- Industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments for the continuous glucose monitoring device (CGMD) market
- Detailed company profiles
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Product, Application, Testing Site, End User, and Geography
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
The continuous glucose monitoring device (CGMD) market is estimated to register a CAGR of 14.9% during the forecast period.
North America dominated the market in 2024.
The rising global prevalence of diabetes, technological advancements in CGM devices, and benefits over conventional glucose monitoring are among the factors contributing to market growth.
Abbott Laboratories; Dexcom Inc.; Ypsomed Holding AG; Medtronic; F. Hoffmann-La Roche Ltd; Senseonics Holdings Inc; i-SENS Inc.; A. Menarini Diagnostics s.r.l; Tandem Diabetes Care, Inc.; and Medtrum Technologies Inc. are among the key players operating in the Continuous glucose monitoring device (CGMD) market.
The continuous glucose monitoring device (CGMD) market is estimated to reach US$ 33.21 Billion by 2031.
The List of companies - Continuous Glucose Monitoring Device (CGMD) Market
- Abbott Laboratories
- Dexcom Inc.
- Ypsomed Holding AG
- Medtronic
- F. Hoffmann-La Roche Ltd
- Senseonics Holdings Inc
- i-SENS Inc.
- A. Menarini Diagnostics s.r.l
- Tandem Diabetes Care, Inc.
- Medtrum Technologies Inc.
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Trends and growth analysis reports related to Continuous Glucose Monitoring Device (CGMD) Market
Aug 2025
Wheelchair and Mobility Aids Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Wheelchairs (Manual, Powered, Power Assisted, and Accessories), Mobility Scooters, Walking Aids, and Others), Application (Neurologically Impaired, Handicap Patients, and Other Applications), End User (Homecare, Hospitals and Clinics, Rehabilitation Centers, and Others), and Distribution Channel (Online and Offline)
Aug 2025
Cystoscopy and Ureteroscopy Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product Type [Cystoscope (Rigid and Flexible), and Ureteroscope (Flexible and Semi-Flexible)], Procedure (Stone Management, Bladder Cancer, Benign Prostatic Hyperplasia, and Others), Technology (Fiberoptic and Video), Usage Type (Reusable and Single Use), End User (Hospitals, Ambulatory Surgical Centers and Specialty Clinics), and Geography (North America, Europe, Asia Pacific, Middle East and Africa, South and Central America)
Aug 2025
Cancer Drugs Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Therapy Type (Chemotherapy, Targeted Therapy, Immunotherapy, Hormone Therapy, and Other Therapy Types), By Indications (Blood Cancer, Lung Cancer, Breast Cancer, Colorectal Cancer, Prostate Cancer, Stomach Cancer, Cervical Cancer, Liver and Intrahepatic Bile Ducts Cancer, Thyroid Cancer, and Other Indications), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Stores), and Geography
Aug 2025
Walking Aids Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Canes, Crutches, Walkers, Rollators, and Others), Age Group (Adults and Pediatric), Application (Neurologically Impaired, Handicap Patients, and Others), End User (Homecare, Hospitals and Clinics, Rehabilitation Centers, and Others), and Distribution Channel (Online and Offline)
Aug 2025
Infectious Disease In vitro Diagnostics Market
Size and Forecast (2021-2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: Application (HIV or AIDS, Tuberculosis, Hepatitis B and C, Malaria, and Others), End User (Hospitals and Clinics, Diagnostic Laboratories, Blood Bank, and Others), and Geography
Aug 2025
Donor Blood Components Market
Size and Forecast (2021–2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: Blood Component (Red Blood Cells, White Blood Cells, Platelets, Plasma, and Others), Indication (Immunosuppression and Oncology), Application (Anemia Management, Thrombocytopenia Treatment, Coagulopathy Correction, Supportive Care During Chemotherapy, Surgery, and Others), Age Group (Adult and Child), End User (Hospitals, Oncology Centers, Transplant Centers, Ambulatory Surgical Centers, and Others), and Geography
Aug 2025
Aesthetic Injectable Devices Market
Size and Forecast (2021-2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: Product (Dermal Filler, Botulinum Toxin and Others), Dermal Fillers (Calcium Hydroxylapatite, Hyaluronic Acid, Collagen, Poly-L-Lactic Acid, Polymethylmethacrylate, Fat Fillers, and Others), Device Type (Microcannulas, Pre-Filled Syringes, Mesotherapy Guns, and Others), Application (Facial Line Correction, Face Lift, Lip Treatment, Anti-Ageing and Wrinkle Treatment, Acne and Scar Treatment, Stretch Marks, and Others), Age Group (Up to 30, 31-40, 41-50, 51-60, and More Than 60), Gender (Female and Male), End User (Medical Spas, Dermatology Clinics, Hospitals, and Others), and Geography
Aug 2025
ECG Monitoring Equipment Market
Size and Forecast (2021-2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Resting ECG, Stress ECG, Holter Monitors, and Cardiopulmonary Stress Testing Monitors), Lead Type (12-Lead ECG, 3–6 Lead ECG, and Single Lead), Technology [Portable (Wired) ECG System and Wireless ECG System], End User (Hospital and Clinics, Ambulatory Surgical Centers, Cardiac Centers, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)